$ZS

ZSCALER (ZS) Maintained by JP Morgan -- Price Target Raised to $

JP Morgan maintained an Overweight rating on Zscaler (ZS) and raised its price target from $215 to $245. The company's GF Value™ suggests it is 28.2% undervalued, with a GF Score™ of 76/100. Insider selling totaled $6.4M over the past three months. Zscaler operates in cloud-native cybersecurity, serving large enterprises and government agencies.

Original reporting
Published Oct 7, 2026, 5:31 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 7, 2026, 5:55 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$ZS
Bullish
medium confidence
Mentioned
$ZS
Relevance
7/10
AlphAI data visualization · based on gurufocus.com
Decision brief

The 30-second read

$ZSBullishMed
01

Why it matters

The rating lift and target raise suggest a short‑term bullish catalyst, but insider sell activity tempers enthusiasm.

02

Market read

Analyst upgrade could trigger buying pressure in Zscaler and potentially lift related cybersecurity names.

03

What to watch

The price target increase does not address Zscaler's ongoing profitability challenges.

Relevance 7/10Novelty 6/10Timing: immediate

Background

Zscaler is a cloud‑native cybersecurity firm with a market cap of ~$35 B, currently trading around $213.

Company-level read

Ticker impact

$ZSBullishMedium confidence
Context

JP Morgan raised Zscaler's price target to $245 and kept an Overweight rating, indicating a more bullish outlook.

Expected impact

likely upward pressure as investors price in the higher target

Evidence & confidence

The new target reflects confidence in growth and valuation, which can prompt short‑term buying.

Market effects

May boost sentiment toward cybersecurity stocks broadly.

Limited to US and global tech investors.

Modest; primarily affects Zscaler and peers.

Counterpoint

Insider selling and unprofitability could signal caution despite the higher target.

Key entities

  • JP Morgan

    Maintained Overweight rating and raised price target.

Related articles

$ZSMed

Zscaler (ZS) Sets $8B ARR Goal by FY2031 Amid Mixed Analyst View

Zscaler (ZS) aims to reach $8B in annual recurring revenue by FY2031, a 2.4x increase from current revenue. Analysts' views are mixed, with Morgan Stanley lowering its price target to $185 and UBS raising it to $250. The company's P/S ratio is 10.14x, below its historical median of 18.9x, reflecting market skepticism about growth and profitability.

$ZSMed

ZS Maintained by Barclays -- Price Target Raised to $225

Barclays maintained an Overweight rating for Zscaler (ZS) and raised its price target to $225 from $220. GuruFocus values ZS at $296.22, suggesting a 29.1% undervaluation at its current price of $210.08. The company has a GF Score of 76/100, indicating strong growth and valuation but low profitability. Insider selling totaled $6.4M in the last 3 months.

$ZSHigh

RBC Capital maintains Zscaler stock rating on $8B ARR target

RBC Capital reiterated an Outperform rating and $236.00 price target on Zscaler (ZS) after the company's Investor Day, where it set an $8B ARR target for 2031. The stock trades at $210.94, and analysts have raised earnings estimates. Several firms increased price targets, with Cantor Fitzgerald setting the highest at $275.